Advertisement
Screener

BeyondSpring Inc. (BYSI) Capital Expenditures

2.8 / 5 stars · 68/120 Roast Me

BeyondSpring Inc. Capital Expenditures

BeyondSpring Inc. (BYSI) reported Capital Expenditures of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.

Financial Statements › Cash Flow › Investing Activities

us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-14

  • BeyondSpring Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $0.00.
  • BeyondSpring Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
  • BeyondSpring Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
  • BeyondSpring Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
  • BeyondSpring Inc. payments to acquire property, plant, and equipment for fiscal 2025 was $50.00K, a 77.68% decline from fiscal 2024.
  • BeyondSpring Inc. payments to acquire property, plant, and equipment for fiscal 2024 was $224.00K, a 124.00% increase from fiscal 2023.
  • BeyondSpring Inc. payments to acquire property, plant, and equipment for fiscal 2023 was $100.00K.
Period endPayments to Acquire Property, Plant, and Equipment 3 monthPayments to Acquire Property, Plant, and Equipment 6 monthPayments to Acquire Property, Plant, and Equipment 9 monthPayments to Acquire Property, Plant, and Equipment 12 month
2026-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14
$0.00
10-Q · filed 2026-08-14
$0.00
derived: sum of 3 quarters · filed 2026-08-14
$0.00
derived: sum of 4 quarters · filed 2026-08-14
2026-03-31$0.00
10-Q · filed 2026-05-13
$0.00
derived: sum of 2 quarters · filed 2026-05-13
$0.00
derived: sum of 3 quarters · filed 2026-05-13
$0.00
derived: sum of 4 quarters · filed 2026-08-14
2025-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25
$0.00
derived: sum of 2 quarters · filed 2026-03-25
$0.00
derived: sum of 3 quarters · filed 2026-08-14
$50.00K
10-K · filed 2026-03-25
2025-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12
$0.00
derived: sum of 2 quarters · filed 2026-08-14
$50.00K
10-Q · filed 2025-11-12
$77.00K
derived: sum of 4 quarters · filed 2026-08-14
2025-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14
$50.00K
10-Q · filed 2026-08-14
$77.00K
derived: sum of 3 quarters · filed 2026-08-14
$274.00K
derived: sum of 4 quarters · filed 2026-08-14
2025-03-31$50.00K
10-Q · filed 2026-05-13
$77.00K
derived: sum of 2 quarters · filed 2026-05-13
$274.00K
derived: sum of 3 quarters · filed 2026-05-13
$274.00K
derived: sum of 4 quarters · filed 2026-05-13
2024-12-31$27.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25
$224.00K
derived: sum of 2 quarters · filed 2026-03-25
$224.00K
derived: sum of 3 quarters · filed 2026-03-25
$224.00K
10-K · filed 2026-03-25
2024-09-30$197.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12
$197.00K
derived: sum of 2 quarters · filed 2025-11-12
$197.00K
10-Q · filed 2025-11-12
2024-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13
$0.00
10-Q · filed 2025-08-13
2024-03-31$0.00
10-Q · filed 2025-05-12
2023-12-31$100.00K
10-K · filed 2025-03-27
2022-12-31$34.00K
20-F · filed 2023-04-18
2021-12-31$2.81M
derived: 20-F 12 month − 6-K 9 month · filed 2023-04-18
$2.82M
derived: sum of 2 quarters · filed 2023-04-18
$2.84M
derived: sum of 3 quarters · filed 2023-04-18
$2.84M
20-F · filed 2023-04-18
2021-09-30$17.00K
derived: 6-K 9 month − 6-K 6 month · filed 2021-12-30
$31.00K
derived: sum of 2 quarters · filed 2021-12-30
$39.00K
6-K · filed 2021-12-30
$57.00K
derived: sum of 4 quarters · filed 2023-04-18
2021-06-30$14.00K
derived: 6-K 6 month − 6-K 3 month · filed 2021-09-10
$22.00K
6-K · filed 2021-09-10
$40.00K
derived: sum of 3 quarters · filed 2023-04-18
$57.00K
derived: sum of 4 quarters · filed 2023-04-18
2021-03-31$8.00K
6-K · filed 2021-06-16
$26.00K
derived: sum of 2 quarters · filed 2023-04-18
$43.00K
derived: sum of 3 quarters · filed 2023-04-18
$51.00K
derived: sum of 4 quarters · filed 2023-04-18
2020-12-31$18.00K
derived: 20-F 12 month − 6-K 9 month · filed 2023-04-18
$35.00K
derived: sum of 2 quarters · filed 2023-04-18
$43.00K
derived: sum of 3 quarters · filed 2023-04-18
$52.00K
20-F · filed 2023-04-18
2020-09-30$17.00K
derived: 6-K 9 month − 6-K 6 month · filed 2021-12-30
$25.00K
derived: sum of 2 quarters · filed 2021-12-30
$34.00K
6-K · filed 2021-12-30
$34.00K
derived: sum of 4 quarters · filed 2022-04-14
2020-06-30$8.00K
derived: 6-K 6 month − 6-K 3 month · filed 2021-09-10
$17.00K
6-K · filed 2021-09-10
$17.00K
derived: sum of 3 quarters · filed 2022-04-14
$17.00K
derived: sum of 4 quarters · filed 2022-04-14
2020-03-31$9.00K
6-K · filed 2021-06-16
$9.00K
derived: sum of 2 quarters · filed 2022-04-14
$9.00K
derived: sum of 3 quarters · filed 2022-04-14
$9.00K
derived: sum of 4 quarters · filed 2022-04-14
2019-12-31$0.00
derived: 20-F 12 month − 6-K 9 month · filed 2022-04-14
$0.00
derived: sum of 2 quarters · filed 2022-04-14
$0.00
derived: sum of 3 quarters · filed 2022-04-14
$4.00K
20-F · filed 2022-04-14
2019-09-30$0.00
derived: 6-K 9 month − 6-K 6 month · filed 2020-11-17
$0.00
derived: sum of 2 quarters · filed 2020-11-17
$4.00K
6-K · filed 2020-11-17
$114.00K
derived: sum of 4 quarters · filed 2021-04-30
2019-06-30$0.00
derived: 6-K 6 month − 6-K 3 month · filed 2020-09-03
$4.00K
6-K · filed 2020-09-03
$114.00K
derived: sum of 3 quarters · filed 2021-04-30
$198.00K
derived: sum of 4 quarters · filed 2021-04-30
2019-03-31$4.00K
6-K · filed 2020-06-11
$114.00K
derived: sum of 2 quarters · filed 2021-04-30
$198.00K
derived: sum of 3 quarters · filed 2021-04-30
$198.00K
derived: sum of 4 quarters · filed 2021-04-30
2018-12-31$110.00K
derived: 20-F 12 month − 6-K 9 month · filed 2021-04-30
$194.00K
derived: sum of 2 quarters · filed 2021-04-30
$194.00K
derived: sum of 3 quarters · filed 2021-04-30
$207.00K
20-F · filed 2021-04-30
2018-09-30$84.00K
derived: 6-K 9 month − 6-K 6 month · filed 2019-12-18
$84.00K
derived: sum of 2 quarters · filed 2019-12-18
$97.00K
6-K · filed 2019-12-18
$105.00K
derived: sum of 4 quarters · filed 2020-04-30
2018-06-30$0.00
derived: 6-K 6 month − 6-K 3 month · filed 2019-09-18
$13.00K
6-K · filed 2019-09-18
$21.00K
derived: sum of 3 quarters · filed 2020-04-30
$69.00K
derived: sum of 4 quarters · filed 2020-04-30
2018-03-31$13.00K
6-K · filed 2019-07-10
$21.00K
derived: sum of 2 quarters · filed 2020-04-30
$69.00K
derived: sum of 3 quarters · filed 2020-04-30
$75.00K
derived: sum of 4 quarters · filed 2020-04-30
2017-12-31$8.00K
derived: 20-F 12 month − 6-K 9 month · filed 2020-04-30
$56.00K
derived: sum of 2 quarters · filed 2020-04-30
$62.00K
derived: sum of 3 quarters · filed 2020-04-30
$76.00K
20-F · filed 2020-04-30
2017-09-30$48.00K
derived: 6-K 9 month − 6-K 6 month · filed 2017-11-09
$54.00K
derived: sum of 2 quarters · filed 2018-10-23
$68.00K
6-K · filed 2017-11-09
$43.00K
derived: sum of 4 quarters · filed 2019-04-30
2017-06-30$6.00K
derived: 6-K 6 month − 6-K 3 month · filed 2018-10-23
$20.00K
6-K · filed 2018-10-23
-$5.00K
derived: sum of 3 quarters · filed 2019-04-30
$50.00K
derived: sum of 4 quarters · filed 2019-04-30
2017-03-31$14.00K
6-K · filed 2018-06-21
-$11.00K
derived: sum of 2 quarters · filed 2019-04-30
$44.00K
derived: sum of 3 quarters · filed 2019-04-30
2016-12-31-$25.00K
derived: 20-F 12 month − 6-K 9 month · filed 2019-04-30
$30.00K
derived: sum of 2 quarters · filed 2019-04-30
$64.00K
20-F · filed 2019-04-30
2016-09-30$55.00K
derived: 6-K 9 month − 6-K 6 month · filed 2017-11-09
$89.00K
6-K · filed 2017-11-09
2016-06-30$34.00K
6-K · filed 2017-08-21
2015-12-31$40.00K
20-F · filed 2018-04-03

Similar stocks

Stock NameCountryMarket CapPE Ratio
NANOVIRICIDES, INC. (NNVC)United States$0.031B
CHINA PHARMA HOLDINGS, INC. (CPHI)$0.032B
Propanc Biopharma, Inc. (PPCB)$0.032B-0.13
IGC Pharma, Inc. (IGC)United States$0.029B-5.98
Hepion Pharmaceuticals, Inc. (HEPA)United States$0.029B-0.62
Transcode Therapeutics, Inc. (RNAZ)United States$0.029B-0.12
KYNTRA BIO, INC. (KYNB)United States$0.028B0.17
Context Therapeutics Inc. (CNTX)United States$0.034B-1.10
ROCKWELL MEDICAL, INC. (RMTI)United States$0.035B
MIRA PHARMACEUTICALS, INC. (MIRA)United States$0.036B-4.30